Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study.

导出 LinkOut

翻译打印收藏纠错

作者： Wencheng,Zhang ^[1] ; Cihui,Yan ^[2] ; Tian,Zhang ^[1] ; Xi,Chen ^[1] ; Jie,Dong ^[3] ; Jingjing,Zhao ^[1] ; Dong,Han ^[1] ; Jun,Wang ^[4] ; Gang,Zhao ^[5] ; Fuliang,Cao ^[6] ; Dejun,Zhou ^[6] ; Hongjing,Jiang ^[7] ; Peng,Tang ^[7] ; Lujun,Zhao ^[1] ; Zhiyong,Yuan ^[1] ; Quanren,Wang ^[8] ; Ping,Wang ^[1] ; Qingsong,Pang ^[1]

作者单位： Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China. ^[1] Department of Immunology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China. ^[2] Department of Nutrition Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China. ^[3] Department of Radiotherapy, The Fourth Hospital of Hebei Medical University, Hebei Clinical Research Center for Radiation Oncology, Shijiazhuang, China. ^[4] Department of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China. ^[5] Department of Endoscopy Diagnosis and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China. ^[6] Department of Esophageal Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China. ^[7] Jiangsu Hengrui Pharmaceuticals Co., Ltd., Lianyungang, China. ^[8]

关键词 Esophageal squamous cell carcinoma PD-1 camrelizumab chemoradiotherapy immunotherapy radiotherapy

主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);顺铂(Cisplatin);食管肿瘤(Esophageal Neoplasms);头颈部肿瘤(Head and Neck Neoplasms);人类(Humans);生活质量(Quality of Life)

DOI 10.1080/2162402X.2021.1971418

PMID 34616588

发布时间 2021-10-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交